Navigation Links
Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes
Date:3/10/2011

SAN DIEGO, March 10, 2011 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that it was issued United States Reissue Patent No. RE42,190 with claims to methods of identifying compounds that modulate the activity of the GPR119 receptor. This invention stems from the discovery by Arena's scientists of the GPR119 receptor, a target for identifying small molecules for the treatment of diabetes.

"Targeting GPR119 with small molecules represents a promising new approach for the treatment of type 2 diabetes," stated Dominic P. Behan, Ph.D., Arena's Senior Vice President and Chief Scientific Officer. "Our growing GPR119 patent portfolio covers technologies and tools that are useful in identifying orally active drug candidates. We are pursuing exclusive partnering opportunities for our internally discovered GPR119 agonists, including APD597 and next-generation compounds, and non-exclusive licensing opportunities for our portfolio of patents and patent applications related to the discovery and development of GPR119 receptor agonists."

Arena recently had additional GPR119 patent successes: United States Patent No. 7,893,235 issued with claims to isolated GPR119 nucleic acid sequences as well as vectors, plasmids and host cells containing those sequences; and United States Patent No. 7,816,492 issued with claims to isolated and recombinant GPR119 amino acid sequences. In addition, Arena holds patents on related GPR119 subject matter issued by patent offices of foreign jurisdictions, including the European Patent Office (EP 1133559, EP 1584683 and EP 1849866) as well as the patent offices of Canada, Australia, South Korea, Mexico, Hong Kong and New Zealand.

The technologies covered by Arena's patents and patent applications are related to the discovery and development of GPR119 receptor agonists, including materials and methods that may be used to id
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 11
2. Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
3. Arena Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
4. Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
5. Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA
6. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension
7. Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
8. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
9. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
10. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
11. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Boston Children,s Hospital,s Global Pediatric Summit + ... an "Innovation Tank" – a forum designed to give ... business or product solution to a panel of acclaimed ... to accelerate the innovation and bring it to market. ... October 31, will be moderated by Daymond John ...
(Date:7/24/2014)... , July 24, 2014  To help ... cardiovascular market that could impact patient care and ... 2014 CV Watch , "Innovations in Cardiovascular Devices."  ... hospitals with guidance and details on promising new ... needs and understand how these options impact the ...
(Date:7/24/2014)... part of its ongoing effort to help women pharmacists become ... Boot Camp on July 26 as part of the company,s ... The Boot Camp is designed to ... their own pharmacies.  Now in its third year, the Cardinal ... pharmacists who dream of owning a pharmacy.   ...
Breaking Medicine Technology:Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 2New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 3'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 2'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 3'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 4
... Association of Clinical Research Organizations (ACRO), which represents the ... and the public in the U.S. and worldwide, issued ... Implications of the Globalization of Clinical Research" published in ... England Journal of Medicine : The article by ...
... Journal of Medicine employs Quest Diagnostics, blood-based leukemia testingMADISON, ... specimens may detect abnormal white blood cells in patients ... develops, according to research published in the current issue ... Medicine . The finding may lead to a better ...
Cached Medicine Technology:ACRO Comments on NEJM Article on Globalization of Clinical Research 2ACRO Comments on NEJM Article on Globalization of Clinical Research 3Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 2Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 3Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 4
(Date:7/24/2014)... A new study led by the Translational Genomics Research ... viruses and the immune system during HIV infection. , ... to infect others based on their blood viral ... in their semen despite having low levels in their ... the virus can be found in different parts of ...
(Date:7/24/2014)... London, UK (PRWEB) July 24, 2014 Memantine ... and was first marketed in Germany under the brand name ... and other nations as Ebixa and in the USA to ... of USD 420 million in 2013. In the US, Forest ... , Patent protection expiry in Canada, Australia and the European ...
(Date:7/24/2014)... 24, 2014 Members of the Iowa State ... CCIM, Senior Associate of Sales at OutcomesMTM, as their Chairperson. ... to the Board and that his peers chose to keep ... provide the best I can for the citizens of Iowa,” ... positioned to provide a special insight to concerns and issues ...
(Date:7/24/2014)... In a recent report by CBS News, the district capital ... criminal penalties associated with possession of small amounts of marijuana. ... Washington DC, giving it one of the most tolerant marijuana ... possession of one ounce of marijuana or less with a ... an ounce of marijuana remain criminal offenses under the new ...
(Date:7/24/2014)... received the Human Papillomavirus Vaccination (HPV) even after ... Pap test results than those who were never ... Sexually Transmitted Diseases . , Researchers from ... of Medicine conducted a cross-sectional study of 235 ... cytology testing. HPV status and demographic and behavioral ...
Breaking Medicine News(10 mins):Health News:TGen-led study seeks to understand why some HIV-positive men are more infectious 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 3Health News:Wolnerman Re-elected as Chairperson of Iowa State Board of Health 2Health News:Washington D.C. Decriminalizes Marijuana 2
... Pilot animal study shows promising results in the treatment of ... ... (Vocus) September 9, 2008 -- A pilot animal ... Boston] provides preliminary evidence that delivering neural stem cells (NSC) ...
... WEXFORD, Penn., Sept. 9 Millennium Pharmacy Systems,Inc., ... enabled pharmacy,solutions to senior healthcare facilities, announced today ... Mr. Scardina has served on,the Millennium Board of ... as an independent consultant after serving as an ...
... TARRYTOWN, N.Y., Sept. 9 Focus 28, Inc. ... its new next generation line of,meal replacements and ... of bariatric patients. According to the company,Bariatric RX ... food,supplements also utilize Double A Technology (AAT), a ...
... Mark Jones and William Reed with colleagues at the ... use of Tasers related to ethnicity, gender, race and ... the Use of Conducted Energy Devices by the Houston ... "Conducted Energy Device Program Performance Audit," released by the ...
... 9 Governor Edward G.,Rendell today announced the ... as Secretary of the Pennsylvania Department of Health ... passionate voice for protecting and improving,the health of ... as an effective leader, addressing a variety of,issues ...
... for the Retirement ... month, NORTH CONWAY, N.H., Sept. 9 It,s no ... aging population grows, so,does the need to house them. According ... nursing homes, 39,500 assisted living,facilities and 1,900 continuing care retirement ...
Cached Medicine News:Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 2Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 3Health News:Neural Stem Cells May Help Repair Spina Bifida in Utero 4Health News:Focus 28 Begins Shipping Next Generation Line of Meal Replacements and Food Supplements for Bariatric Patients 2Health News:Rice political scientists co-author report on ethnic/racial aspects of Taser use by Houston police 2Health News:Governor Rendell Announces Resignation of Health Secretary Dr. Calvin Johnson 2Health News:SeniorHousingJobs.com Celebrates Its 5th Anniversary 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: